Ticker Hub
ALGS — AI Analysis & Sentiment
3 recent AI-generated analyses for ALGS. Sentiment and confidence insights updated continuously.
Aligos Therapeutics Presents Positive Data at the EASL Congress 2026
Aligos Therapeutics presented promising early-stage clinical and preclinical data for its lead drug candidates for liver diseases. This positive de...
May 27, 2026Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation
Aligos Therapeutics received FDA Fast Track Designation and positive Phase 2 interim results for its HBV drug, significantly advancing its pipeline...
Apr 14, 2026Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
Aligos Therapeutics announced positive clinical data for its hepatitis B and coronavirus drug candidates, which could enhance its pipeline's prospe...
Feb 23, 2026